Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 03, 2022 09:00 ET | Source: Isracann Biosciences Inc.

Isracann Biosciences Announces Closing of First Tranche of $0.05 Unit Private Placement

VANCOUVER, British Columbia, Aug. 03, 2022 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company”) is pleased to announce that it has closed the first...
April 15, 2022 08:30 ET | Source: Isracann Biosciences Inc.

Isracann Biosciences Renews Leadership to Meet Changing Demands

VANCOUVER, British Columbia, April 15, 2022 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company”) is pleased to announce that further to its...
February 24, 2022 16:09 ET | Source: Isracann Biosciences Inc.

UPDATE - Isracann Signs LOI to Acquire Natural Health Medicine Developer

VANCOUVER, British Columbia, Feb. 24, 2022 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company” or “Isracann”) a biosciences company focused on...
February 23, 2022 08:30 ET | Source: Isracann Biosciences Inc.

Isracann Signs LOI to Acquire Natural Health Medicine Developer

VANCOUVER, British Columbia, Feb. 23, 2022 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company” or “Isracann”) a biosciences company focused on...